SCHEMBL6025396

SCHEMBL6025396

CC(CCO)CNCCCO

nearest known ligand 0.34

Predicted protein targets (top 6)

geneUniProtsupporting neighboursconfidence
ALDH1A1 P00352 1/20 0.34
ALOX15 P16050 1/20 0.34
TSHR P16473 1/20 0.32
PKM P14618 1/20 0.31
TRPV3 Q8NET8 1/20 0.31
TRPA1 O75762 1/20 0.31

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL9407524 0.88 PKM (0.34) ALDH1A1TSHRPKM
SCHEMBL11595660 0.83 ALDH1A1 (0.41) ALDH1A1ALOX15TSHRTRPV3TRPA1
SCHEMBL24176235 0.82 TSHR (0.42) ALDH1A1ALOX15TSHRTRPV3TRPA1
SCHEMBL22144380 0.82 TSHR (0.42) ALDH1A1ALOX15TSHRTRPV3TRPA1
SCHEMBL13661597 0.82 TSHR (0.32) ALDH1A1TSHRPKM
SCHEMBL19407254 0.82 TSHR (0.32) ALDH1A1TSHRPKM
SCHEMBL13118766 0.80 GABBR2 (0.35) PKM
SCHEMBL7948204 0.79
SCHEMBL9407504 0.78
SCHEMBL10597697 0.78 TSHR (0.36) ALDH1A1TSHR

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1613619-A1 QUINAZOLINE DERIVATIVES FOR TREATMENT OF CANCER AstraZeneca AB (SE) 2006-01-11 EP disclosed
WO-2004094410-A1 CHEMICAL COMPOUNDS ASTRAZENECA AB (SE) 2004-11-04 WO disclosed
EP-1463506-A1 SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES Astrazeneca AB (SE) 2004-10-06 EP disclosed
WO-2003055491-A1 SUBSTITUTED QUINAZOLINE DERIVATIVES AS INHIBITORS OF AURORA KINASES ASTRAZENECA AB (SE) 2003-07-10 WO disclosed